comprehensive -WSS

comprehensive

author：explore 2025-10-01 22:48:48 - browse：2222

How does a drug industry lobbying group move forward after years of upheaval, including having four CEOs in four years?

This week on “The Readout LOUD,” STAT’s Chief Washington Correspondent Rachel Cohrs Zhang joins us to discuss the layoffs at trade group BIO and how things may be changing at the trade group. We also invite STAT reporter Eric Boodman on to talk about his new investigative series of stories exploring how Black women with sickle cell disease were coerced into getting sterilized.

To read the first article in the Coercive Care investigative series and find future installments, go here; For more on the layoffs at BIO, go here; To keep tabs on health policy and BIO’s reorganization, sign up for the D.C. Diagnosis newsletter here; And you can sign up for Adam’s new newsletter, Biotech Scorecard, here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

focus

WSS

Why ADHD is under

It's time to get medical device identifiers over the finish line

Histogen: Failed biotech offers rare public look inside

Sana to lay off nearly a third of staff, de

N.Y. state detects polio case, first in the U.S. since 2013

Lecanemab for Alzheimer's is coming. Is the health system ready?

focus

comprehensive

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

HCA discloses massive data breach affecting 11 million patients

23andMe had bad news about my health. I wish a person had delivered it

3 questions for the future of Biden's cancer moonshot

Psychedelics group wrestles with new pharma identity

Iowa House, Senate pass 6

Activists slam private health insurers over coverage restrictions

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

How to save PrEP access — and even expand it

Leqembi, other new Alzheimer’s drugs require better biomarkers

Wikipedia

FDA authorizes Novavax’s updated Covid

Biden launches a new push to limit health care costs

VC firm General Catalyst wants to buy a health system

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

It's time to get medical device identifiers over the finish line

Leqembi, other new Alzheimer’s drugs require better biomarkers

hotspot

focus

hotspot

explore